Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity
- 1 March 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 32 (3), 715-720
- https://doi.org/10.1021/jm00123a038
Abstract
Note: In lieu of an abstract, this is the article's first page.This publication has 8 references indexed in Scilit:
- Plant antitumor agents. 28. Resolution of a key tricyclic synthon, 5'(RS)-1,5-dioxo-5'-hydroxy-2'H,5'H,6'H-6'-oxopyrano[3',4'-f].DELTA.6,8-tetrahydroindolizine: total synthesis and antitumor activity of 20(S)- and 20(R)-camptothecinJournal of Medicinal Chemistry, 1987
- Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.Proceedings of the National Academy of Sciences, 1987
- Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin.The EMBO Journal, 1987
- RELATIONSHIP BETWEEN THE INTRACELLULAR EFFECTS OF CAMPTOTHECIN AND THE INHIBITION OF DNA TOPOISOMERASE-I IN CULTURED L1210 CELLS1987
- Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.Journal of Biological Chemistry, 1985
- Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogsJournal of Medicinal Chemistry, 1980
- Studies on the effects of the antitumor agent camptothecin and derivatives on deoxyribonucleic acidBiochemical Pharmacology, 1980
- Prodrug analogs of the antitumor alkaloid camptothecinJournal of Medicinal Chemistry, 1979